DCP Capital is a China-focused private equity investment firm backing growth and later-stage companies across consumer, healthcare, food and beverage, manufacturing, insurance, TMT and related sectors. It invests across China with portfolio exposure in Singapore, Canada and the United States. Relevant portfolio areas include medical devices, life sciences, biotechnology, pharmaceuticals, nutrition, semiconductors and consumer goods, with portfolio companies such as Ping An Insurance, Mengniu Dairy, China Feihe, Ambrx Biopharma and YAGEO Corporation.